Surgery Partners (SGRY) Receivables (2014 - 2026)

Surgery Partners has disclosed Receivables across 13 years of filings, most recently posting $616.6 million for Q2 2026.

• In Q2 2026, Receivables rose 9.5% year-over-year to $616.6 million; the TTM figure through Jun 2026 stood at $616.6 million (up 9.5% YoY), while the FY2025 annual figure was $602.2 million, up 3.99% from the prior year.
• Receivables came in at $616.6 million for Q2 2026 at Surgery Partners, up from $603.4 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $616.6 million in Q2 2026 to a low of $412.0 million in Q2 2022.
• Average Receivables over 5 years is $513.3 million, with a median of $509.9 million recorded in 2023.
• Year-over-year, Receivables grew 17.31% in 2024 and gained 3.99% in 2025.
• Over 5 years, Receivables stood at $456.3 million in 2022, then increased by 8.79% to $496.4 million in 2023, then increased by 16.66% to $579.1 million in 2024, then grew by 3.99% to $602.2 million in 2025, then gained by 2.39% to $616.6 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $616.6 million in Q2 2026, $603.4 million in Q1 2026, and $602.2 million in Q4 2025.